South Korea's stock market rose sharply, buoyed by a rebound in U.S. technology stocks and falling international oil prices. The KOSPI regained the 5,200 level, while the KOSDAQ climbed above 650, triggering buy-sidecars in both markets that temporarily suspended the effect of program buy orders. Although gains narrowed somewhat from early in the session, the recovery continued, led by semiconductor stocks.


The Philadelphia Semiconductor Index rose more than 6%, with Samsung Electronics and SK hynix leading the market rebound. Buying also spread to semiconductor equipment and parts makers, including Jusung Engineering, EO Technics and Simmtech, and most of the stocks with the largest market capitalizations advanced.


In a market where funds are flowing rapidly into sectors that had suffered steep declines, CEO Kim Jin said investors should look for sustained buying momentum rather than simply a technical rebound.

Strong Buying Across Both Major Indexes... Which Earnings- and Fund-Flow-Focused Stocks Is CEO Kim Jin Watching? View original image

He said that even when the index rises strongly, investors need to assess whether foreign investors will continue buying and distinguish companies whose performance is supported by solid results.


■ Key Stocks Drawing Buying Interest in the Rebound (Click)


Among individual stocks, NHN reported consolidated third-quarter revenue of KRW 758.3 billion and operating profit of KRW 58.8 billion, confirming its earnings growth potential. Its payments and cloud businesses drove growth, while plans to expand its AI data centers also drew attention, concentrating trading in the stock.


■ Check CEO Kim Jin's Market Strategy and Stocks of Interest (Free Access)


Pum-Tech Korea also drew attention for its improved third-quarter results and expectations of expanded production capacity. On the back of growing demand for cosmetic containers and plans to expand a new plant, securities firms successively raised their earnings forecasts and target prices. HanAll Biopharma was cited as a biotech stock with a distinctive catalyst, as clinical results for its autoimmune disease treatment drew investor interest.


CEO Kim Jin stressed that investors should not blindly chase the index rebound. Instead, he said, they should check whether buying momentum in semiconductor stocks is holding and narrow their focus to companies with distinct catalysts, such as earnings, clinical trials and new businesses.


▶ [Market Strategy] CEO Kim Jin Reveals Key Stocks to Watch After the Rebound (Click)


*** Recent Hot Stocks ***

NHN, Jusung Engineering, EO Technics, Pum-Tech Korea, HanAll Biopharma



※ This content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility rests with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing